Regarding MM, activation of SGK1 by interleukin 6 (IL-6) stimulation promotes cell cycle progression and DNA synthesis [19] and prevents endoplasmic reticulum-induced apoptosis by bortezomib [20]. Here, SGK1 is linked to Miyoshi myopathy.